Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
Carlo Visco, A. Tzankov, Z. Xu-Monette, Roberto N. Miranda, Yu Chuan Tai, Yan Li, Wei-min Liu, E. d'Amore, Yong Li, S. Montes-Moreno, K. Dybkær, April Chiu, A. Orazi, Y. Zu, Govind Bhagat, Huan-You Wang, Cherie H. Dunphy, Eric D. His, X. F. Zhao, W. Choi, Xiaoying Zhao, J. H. van Krieken, Qin Huang, Weiyun Ai, Stacey O'Neill, M. Ponzoni, A. Ferreri, Brad S. Kahl, Jane N Winter, Ronald S. Go, S. Dirnhofer, Miguel A. Piris, M. Møller, Lin Wu, L. J. Medeiros, Ken H Young
Haematologica